These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22454867)

  • 1. The effect of age on the hydroxylation of amylobarbitone sodium in man.
    Irvine RE; Grove J; Toseland PA; Trounce JR
    Br J Clin Pharmacol; 1974 Feb; 1(1):41-3. PubMed ID: 22454867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of paracetamol on amylobarbitone hydroxylation in man: a gas chromatographic method for simultaneous estimation of underivatized paracetamol and barbiturates.
    Kinsella HC; Smith S; Rogers HJ; Toseland PA
    J Pharm Pharmacol; 1979 Mar; 31(3):153-6. PubMed ID: 34688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiency.
    Balasubramaniam K; Mawer GE; Pohl JE; Simons PJ
    Br J Pharmacol; 1972 Jun; 45(2):360-7. PubMed ID: 5048653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics of amylobarbitone metabolism in healthy men and women.
    Balasubramaniam K; Lucas SB; Mawer GE; Simons PJ
    Br J Pharmacol; 1970 Jul; 39(3):564-72. PubMed ID: 5472203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of amylobarbitone in patients with chronic liver disease.
    Mawer GE; Miller NE; Turnberg LA
    Br J Pharmacol; 1972 Mar; 44(3):549-60. PubMed ID: 5040665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The excretion of hydroxyamylobarbitone in man after oral administration of amylobarbitone and hydroxyamylobarbitone.
    Grove J; Toseland PA
    J Pharm Pharmacol; 1971 Dec; 23(12):936-40. PubMed ID: 4402019
    [No Abstract]   [Full Text] [Related]  

  • 7. N-Hydroxyamylobarbitone--a metabolite of amylobarbitone?
    Gilbert JN; Nelmes PT; Powell JW; Murray S
    J Pharm Pharmacol; 1978 Sep; 30(9):595. PubMed ID: 29107
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of low doses of amylobarbitone sodium and diazepam on human performance.
    Hart J; Hill HM; Bye CE; Wilkinson RT; Peck AW
    Br J Clin Pharmacol; 1976 Apr; 3(2):289-98. PubMed ID: 973963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the clearance of amylobarbitone from a single plasma measurement.
    Bachmann K
    Br J Clin Pharmacol; 1987 Jan; 23(1):94-8. PubMed ID: 3814466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-dose study on the human metabolism of amylobarbitone.
    Baldeo WC; Gilbert JN; Powell JW
    Xenobiotica; 1979 Apr; 9(4):205-8. PubMed ID: 483856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent behavioural and electroencephalographic changes after single doses of nitrazepam and amylobarbitone sodium.
    Malpas A; Rowan AJ; Boyce CR; Scott DF
    Br Med J; 1970 Jun; 2(5712):762-4. PubMed ID: 4913785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of diazepam, noradiazepam and amylobarbitone after short-term treatment of anxious patients.
    Tansella M; Zimmermann Tansella C; Ferrario L; Preziati L; Tognoni G; Lader M
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):68-75. PubMed ID: 347466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estimation of amylobarbitone and hydroxyamylobarbitone in serum by gas liquid chromatography.
    Balasubramaniam K; Mawer GE; Rodgers EM
    Br J Pharmacol; 1969 Oct; 37(2):546P-547P. PubMed ID: 5348459
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific oculomotor deficits after amylobarbitone.
    Tedeschi G; Bittencourt PR; Smith AT; Richens A
    Psychopharmacology (Berl); 1983; 79(2-3):187-9. PubMed ID: 6405427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of the hydroxyamylobarbitone amylobarbitone ratio.
    Grove J; Toseland PA
    Arh Hig Rada Toksikol; 1970; 21(4):353-62. PubMed ID: 5525122
    [No Abstract]   [Full Text] [Related]  

  • 16. N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects.
    Tansella M; Siciliani O; Burti L; Schiavon M; Zimmermann C; Gerna M; Tognoni G; Morselli PL
    Psychopharmacologia; 1975; 41(2):81-5. PubMed ID: 1098085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and electrocardiographic effect of ebastine in young versus elderly healthy subjects.
    Huang MY; Argenti D; Wilson J; Garcia J; Heald D
    Am J Ther; 1998 May; 5(3):153-8. PubMed ID: 10099053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjects.
    Hindmarch I; Parrott AC; Arenillas L
    Br J Clin Pharmacol; 1977 Apr; 4(2):229-33. PubMed ID: 16635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers.
    Zhao JJ; Rogers JD; Holland SD; Larson P; Amin RD; Haesen R; Freeman A; Seiberling M; Merz M; Cheng H
    Biopharm Drug Dispos; 1997 Dec; 18(9):769-77. PubMed ID: 9429741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of amylobarbitone, butobarbitone, pentobarbitone and quinalbarbitone and the hydroxylated metabolites in man.
    Robinson AE; McDowall RD
    J Pharm Pharmacol; 1979 Jun; 31(6):357-65. PubMed ID: 39132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.